ATF4 is a novel regulator of MCP-1 in microvascular endothelial cells
© Huang et al.; licensee BioMed Central. 2015
Received: 6 January 2015
Accepted: 31 March 2015
Published: 17 April 2015
Monocyte chemoattractant protein-1 (MCP-1) is a major chemokine that recruits monocyte/macrophage to the site of tissue injury and plays a critical role in microvascular complications of diabetes. However, the mechanisms underlying the regulation of MCP-1 are not fully understood. The present study aims to explore the role of activating transcription factor 4 (ATF4), an ER stress-inducible transcription factor, in regulation of MCP-1 expression and production in brain and retinal microvascular endothelial cells.
For in vitro study, primary brain microvascular endothelial cells isolated from ATF4 knockout mice or mouse retinal endothelial cells were treated with lipopolysaccharide (LPS) to induce MCP-1 expression. ATF4 expression/function was manipulated by adenoviruses expressing wild type ATF4 (Ad-ATF4) or a dominant negative mutant of the protein (Ad-ATF4DN). For in vivo study, MCP-1 expression was induced by intravitreal injection of LPS or Ad-ATF4 in heterozygous ATF4 knockout or wild type mice.
LPS treatment induced a dose- and time-dependent increase in ATF4 expression, ER stress and MCP-1 production in brain and retinal microvascular endothelial cells. Overexpression of ATF4 in endothelial cells significantly increased the secretion of MCP-1 and promoted THP-1 monocyte-endothelial cell adhesion. Conditioned medium from ATF4-overexpressiing endothelial cells significantly enhanced THP-1 cell migration. Consistently, intravitreal injection of Ad-ATF4 remarkably enhanced retinal levels of MCP-1 and promoted inflammatory cell infiltration into the vitreous and retina. In contrast, LPS-induced MCP-1 upregulation was markedly attenuated in ATF4-deficient endothelial cells and in retinas of ATF4 knockout mice, suggesting that ATF4 is essential for LPS-induced MCP-1 production in endothelial cells and in the retina. Mechanistically, overexpression of ATF4 enhanced, while inhibition of ATF4, attenuated the basal and LPS-stimulated phosphorylation of NF-κB, P38, and JNK. Furthermore, pharmacological inhibition of NF-κB, P38, or JNK significantly reduced ATF4-stimulated MCP-1 secretion from endothelial cells.
Taken together, our results suggest a critical role of ATF4 in the regulation of MCP-1 production in retinal and brain microvascular endothelial cells, which may contribute to inflammation-related endothelial injury in diseases such as diabetic retinopathy.
KeywordsMonocyte chemoattractant protein 1 Microvascular endothelial cells Activating transcription factor 4
The endoplasmic reticulum (ER) is the central hub for protein biosynthesis, protein folding and regulation of intracellular calcium concentration. A delicate balance between protein synthesis and folding is vital for cell survival and function. However, this homeostasis can be disturbed in some physiological or pathophysiological conditions, due to increased demand of protein production, reduced capacity of protein folding, altered redox status in the ER, or perturbed protein and calcium trafficking . As a consequence, unfolded or misfolded proteins accumulate in the ER, resulting in activation of the unfolded protein response (UPR) by three ER membrane proteins: inositol requiring trans-membrane kinase/endonuclease 1 (IRE1), activating transcription factor 6 (ATF6) and protein kinase (PKR)-like endoplasmic reticulum kinase (PERK). PERK, through phosphorylation of eukaryotic translation initiation factor 2α (eIF2α), suppresses global protein translation but increases the production of activating transcription factor 4 (ATF4), inducing the expression of C/EBP homologous protein (CHOP) . Chronic ER stress results in apoptosis and cell death, contributing to retinal degeneration . In addition, our recent studies have shown that ER stress and the PERK/eIF2α/ATF4/CHOP pathway are involved in regulation of immune response and retinal vascular injury in diabetic retinopathy, a common complication of diabetes [4,5]. However, the mechanisms underlying ER stress-related inflammatory signaling are not fully understood.
The innate immune system is a critical component of host defense, which recognizes pathogen-associated molecules through pathogen-recognition receptors, such as Toll-like receptors (TLRs) . TLR4 recognizes specific structural components of pathogens, such as lipopolysaccharide (LPS), resulting in the activation of MyD88-dependent and TRIF-dependent pathways. The MyD88-dependent pathway primarily activates signaling proteins including TGF-beta-activated kinase (TAK)-nuclear factor (NF)-κB and TAK-mitogen-activated protein kinase (MAPK)-AP-1. The activation of these transcription factors induces the expression of multiple pro-inflammatory factors, such as monocyte chemoattractant protein-1 (MCP-1). Intriguingly, several studies have revealed a role of ER stress and the UPR in regulation of the TLR signaling [8,9]. In macrophages, induction of the UPR acts synergistically with LPS in production of cytokines such as interleukin 23 and interleukin 17 [10,11]. Moreover, activation of ATF4 has been shown to promote the secretion of interleukin 6, interleukin 8 and RANTES through an interaction with c-Jun of the TLR4-MyD88 pathway. Paradoxically, recent work by Woo and colleagues indicates that pretreatment with low dose of LPS selectively suppresses the PERK-ATF4-CHOP pathway  and protects mice from tunicamycin-induced renal dysfunction and hepatosteatosis . These findings indicate some complex interactions between the UPR and TLR4 signaling, which may contribute to the tight control of inflammatory factor expression during tissue injury.
In diabetic retinopathy, increased MCP-1 production is a major factor responsible for leukocyte migration and interaction with endothelium resulting in microvascular injury of the retina. Previously we have shown that ATF4 was upregulated in diabetic retina and was required for pro-inflammatory genes VEGF (vascular endothelial growth factor) and ICAM-1 (intercellular adhesion molecule 1) expression in Müller and vascular endothelial cells [4,5]. In the present study, we investigated the role of ATF4 in MCP-1 production from brain and retinal microvascular endothelial cells and explored the underlying mechanisms by which ATF4 regulates MCP-1 expression.
Materials and methods
Thapsigargin (TG) was obtained from Sigma-Aldrich (St. Louis, MO). JNK inhibitor II (SP600125), P38 inhibitor (SB203580), and p44/42 inhibitor (U0126) were purchased from Calbiochem (San Diego, CA). NF-κB inhibitor (Ro106-9920) was obtained from Tocris Bioscience. Endothelial cell growth supplement kit was obtained from Millipore (Billerica, MA). Protease inhibitor cocktail, anti-ATF4, anti-CHOP, antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-phospho-eIF2α, anti–eIF2α, anti-phospho-JNK, anti- phospho-P38, anti-phospho-NF-κB, and anti- phospho-p44/42 antibodies were obtained from Cell Signaling (Danvers, MA), and anti-β-actin antibody was from Abcam (Cambridge, MA). Horseradish peroxidase–conjugated, fluorescein isothiocyanate avidin (FITC)-conjugated, or biotinylated secondary antibodies, and DAPI were purchased from Vector Laboratories (Burlingame, CA). Cy3-conjugated anti-rabbit IgG was obtained from Jackson ImmunoResearch Laboratories (West Grove, PA).
Immortalized mouse retinal endothelial cells  were grown at 33°C in DMEM with 10% FBS and 30 μg/ml endothelial cell growth supplement. THP-1 cells were obtained from ATCC (Manassas, VA) and were routinely maintained in RPMI 1640 medium with 10% fetal bovine serum and 0.05 mM 2-mercaptoethanol. Mouse brain microvascular endothelial cells were isolated as described previously  and were grown in DMEM with 20% FBS. To better recapitulate the in vivo situation and to reduce the confounding effects of the serum, subconfluent cells were starved with DMEM containing 1% FBS to acquire quiescence prior to the desired treatments.
C57BL/6 J mice were purchased from the Jackson Laboratory (BarHarbor,ME). ATF4 knockout mice were kindly provided by Tim Townes, Ph.D. (University of Alabama at Birmingham) [4,5]. Care, use, and treatment of all animals were in strict agreement with the guidelines of the Association for Research in Vision and Ophthalmology Statement for the Use of Animals in Ophthalmic and Visual Research and approved by the institutional animal care and use committees in the University of Oklahoma Health Sciences Center.
Intravitreal injection of adenovirus
Intravitreal injection was performed in deeply anesthetized mice using an UltraMicroPump (World Precision Instruments, Sarasota, FL). Briefly, an incision was made 1 mm behind the limbus with a sharp-edge 31-gauge needle. The 34-gauge blunt needle mounted on a 10-μl microsyringe was inserted into the vitreous cavity. One microliter of vehicle containing 109 viral particles was delivered into the vitreous with one foot-switch press.
Transduction of microvascular endothelial cells with adenovirus
Adenoviruses expressing wild-type ATF4 (Ad-ATF4) or a dominant negative mutant of ATF4 (Ad-ATF4DN) were generated and propagated as described previously [4,5]. Empty adenoviruses that did not contain a transgene were used as control. Retinal or brain microvascular endothelial cells were transduced with adenoviruses at 30 MOI (multiplicity of infection) (for immortalized mouse retinal endothelial cells) or 100 MOI (for primary mouse brain endothelial cells) for 24 h. Cells were then exposed to DMEM containing 1% FBS overnight to acquire quiescence prior to the desired treatments.
Histology and immunofluorescence
For retinal histological study, eyeballs were immersed in Per-fix (4% paraformaldehyde, 20% isopropanol, 2% trichloroacetic acid, 2% zinc chloride) overnight and embedded in paraffin. Sagittal sections of 5 μm thickness were stained with hematoxylin and eosin (HE) and examined under an Olympus microscopy (Tokyo, Japan). Immunofluorescence study on retinal cryosections was prepared as previously described . Briefly, the sections were immunostained with anti-CD11b antibody (1:100 dilution) overnight at 4°C. Negative controls without primary antibody incubation were included. After multiple washes, the sections were incubated with Cy3-conjugated secondary antibody (Molecular Probes, Eugene, OR, USA). DAPI was used to label cell nuclei.
Total RNA was extracted using the RNeasy Mini Kit (Qiagen). cDNA was synthesized using the iScript cDNA Synthesis Kit, and Real-time qPCR was performed using SYBR Green PCR Master Mix (Bio-Rad Laboratories, Hercules, CA, USA) on an iCycler iQTM (BioRad, Hercules, CA). Relative mRNA level was calculated by the ΔΔCt method and ribosomal protein L19 (Rlp19) was used as an endogenous control. The sequences of primers for mouse MCP-1 are as following: forward: ATGAGATCAGAACCTACAACT; reverse: TCCTACAGAAGTGCTTGAG.
Transwell migration assay
The transwell migration assay was performed on semi-permeable membranes with pore size of 5 μm (Costar Transwell, Corning, NY). Briefly, THP-1 cells were suspended in RPMI1640 medium supplemented with 1% FBS and 0.5% BSA (Sigma-Aldrich). 1 × 105 cells were seeded in the transwell inserts and allowed to migrate overnight toward the lower compartments with the conditioned medium from endothelial cell culture. The membranes of the inserts were fixed with 4% paraformaldehyde. Cells on the top surface of the membrane were mechanically removed, and those migrated to the bottom of the membrane were stained with DAPI (4’, 6- diamidino-2-phenylindole). Cell numbers were counted in 3 random visual fields, using an Olympus fluorescence microscope (Tokyo, Japan).
Leukocyte adhesion assay
Endothelial cells were grown to 80% confluence in six-well plates and pretreated with LPS or Ad-ATF4 with controls for 24 h. THP-1 cells were added to endothelial culture and incubated for additional 3 h. Unbound THP-1 cells were removed by 3 washes with PBS, and bound THP-1 monocytes were counted from 3 random visual fields under an Olympus microscope (Tokyo, Japan).
Western blot analysis
Cells or retina tissue were lysed in radioimmunoprecipitation assay lysis buffer (RIPA, Santa Cruz). Western blot analysis was performed as described previously [4,5]. The following primary antibodies were used at the indicated dilutions: anti-phospho-eIF2α (1:1,000), anti-eIF2α (1:1,000), anti-ATF4 (1:500), anti-CHOP (1:500), anti-phospho-JNK (1:500), anti-phospho-p38 (1:1000), antiphospho-p44/42(1:1000), anti-phospho-NF-κB (1:1000), and anti-β-actin (1:5,000) antibodies. Horseradish peroxidase-conjugated goat-anti-rabbit IgG (Vector Laboratories, Bulingame, CA) and goat anti-mouse IgG (Vector Laboratories) were used as secondary antibodies.
MCP-1 was quantified using mouse MCP-1 ELISA assay kit (R&D systems, Minneapolis, MN) according to manufacturer’s instructions.
Statistical analysis was performed using Student’s t test when comparing two groups, or ANOVA with Bonferroni’s post hoc test when comparing three or more groups. Statistical significance was accepted as p < 0.05.
LPS increases ER stress and ATF4 expression in microvascular endothelial cells
ATF4 mediates LPS-induced MCP-1 production in microvascular endothelial cells
ATF4 regulates retinal MCP-1 expression and leukocyte infiltration in vivo
Manipulating ATF4 expression in endothelial cells influences leukocyte migration and leukocyte-endothelial adhesion
ATF4 up-regulates MCP-1 through NF-κB and MAPK pathways
We have previously shown that ATF4 is involved in the regulation of inflammatory genes in retinal endothelial and Müller cells [4,5]. However, the mechanisms are not fully defined. Herein, we demonstrate that ATF4 is essential for MCP-1 expression in endothelial cells, likely through promoting the activation of NF-κB and MAPK pathways. ATF4 is a major stress response gene activated in cells under conditions of ER stress and oxidative stress [4,5,17-20]. As a transcription factor, ATF4 regulates a variety of genes involved in multiple biological processes, including hematopoiesis, lens and skeletal development, inflammation, angiogenesis, oxidative stress, and apoptosis. Recently studies suggest that ATF4 is up-regulated in various pathogen-induced-immune responses and participates in the TLR signaling pathways [12,21-23]. Coincidently, other UPR branches are also activated, reflecting the concurrence of ER stress with ATF4 activation [24-29]. Moreover, activation of ATF4 enhances TLR4-induced secretion of pro-inflammatory cytokines (IL-6 and IL-8) in macrophages . In line with these findings, we show that activation of TLR4 by LPS induces ER stress and upregulates ATF4 in brain and retinal microvascular endothelial cells. Over-expression of ATF4 was sufficient to induce MCP-1 expression. In contrast, inhibition of ATF4 significantly attenuated LPS-induced MCP-1 secretion. These observations support our previous findings that ATF4 is an important regulator of retinal inflammatory response and vascular leakage in diabetic retinopathy  and further reveals a role of MCP-1 in ATF4-mediated retinal inflammation.
MCP-1 is a key chemokine that regulates monocyte/macrophage migration and recruitment in inflammatory tissues [31-34]. Herein, we provided several lines of evidence that support a critical role of ATF4 in regulation of MCP-1 production and inflammatory cell infiltration. First, we found the MCP-1 level was increased in the medium from ATF4-overexpressing endothelial cells, and both adhesion and migration of THP-1 cells were enhanced when incubated with this conditioned medium. Second, using the medium from ATF4-deficient endothelial cells impaired monocyte adhesion and migration, even in the presence of LPS. A limitation of these experiments is using THP-1 cells, a human monocyte cell line, to investigate adhesion to murine endothelial cells. Although THP-1 cells have been extensively used for adhesion and migration assays, future studies using murine J774 cells to confirm the results from the current study is necessary. Third, over-expression of ATF4 in vivo promoted macrophage infiltration into the vitreous and retina. These findings indicate that ATF4 is involved in MCP-1 regulation in endothelial cells, which in turn modulates monocyte/macrophage activity and retinal inflammatory response. It is notable that although MCP-1 is abundant in the endothelial culture supernatant, there are likely other secreted factors that are regulated by ATF4 and contribute to macrophage migration. Future studies to eliminate or deactivate MCP-1 protein by applying a neutralising antibody against MCP-1 to the conditioned medium or using supernatant from MCP1-null endothelial cells engineered to overexpress ATF4 are warranted to clarify the role of MCP-1 in mediating the effect of ATF4 upregulation in endothelial cells on macrophage adhesion and infiltration.
LPS activation of the TLR4 signaling, through MyD88-downstream NF-κB and AP-1 pathways, leads to the induction of pro-inflammatory cytokines including MCP-1 [35,36]. Recent studies found that upon LPS stimulation, ATF4 forms dimer with JNK via the AP-1 and CREB binding sites, promoting the secretion of various pro-inflammatory cytokines in human monocytes/macrophages . Our previous work also indicates a crosstalk between ATF4 and classic inflammatory signals including STAT3 and JNK in retinal endothelial and Müller cells, respectively [4,5]. Now, we demonstrate that deletion of ATF4 or inhibition of ATF4 function significantly attenuates the basal and LPS-stimulated phosphorylation of NF-κB, P38, and JNK. In contrast, overexpressing ATF4 is sufficient to activate these signaling molecules, which are required for ATF4-mediated MCP-1 expression. These results have revealed a new mechanism by which ATF4 interacts with TLR4 pathways through activation of MyD88 downstream effectors and, thus, might be a central coordinator for inflammatory response in microvascular endothelial cells in the brain and the retina.
Our data suggest that ATF4 functions as a positive regulator in LPS-triggered MCP-1 production in endothelial cells through multiple pathways. This mechanism could reveal a new target in endothelial cells to prevent vascular pathology associated with monocyte/macrophage-mediated inflammation in diseases such as diabetic microvascular complications.
We thank Dr. Tim Townes (University of Alabama at Birmingham, Birmingham, AL) for ATF4 KO mice. This work is supported, in part, by NIH/NEI grants EY019949 and EY025061, by a grant from American Diabetes Association, and by an Unrestricted Grant to the Department of Ophthalmology, SUNY-Buffalo, from Research to Prevent Blindness (SXZ).
- Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol. 2007;8(7):519–29.View ArticlePubMedGoogle Scholar
- Walter P, Ron D. The unfolded protein response: from stress pathway to homeostatic regulation. Science. 2011;334(6059):1081–6.View ArticlePubMedGoogle Scholar
- Zhang SX, Sanders E, Fliesler SJ, Wang JJ. Endoplasmic reticulum stress and the unfolded protein responses in retinal degeneration. Exp Eye Res. 2014;125C:30–40.View ArticleGoogle Scholar
- Chen Y, Wang JJ, Li J, Hosoya KI, Ratan R, Townes T, et al. Activating transcription factor 4 mediates hyperglycaemia-induced endothelial inflammation and retinal vascular leakage through activation of STAT3 in a mouse model of type 1 diabetes. Diabetologia. 2012;55(9):2533–45.View ArticlePubMed CentralPubMedGoogle Scholar
- Zhong Y, Li J, Chen Y, Wang JJ, Ratan R, Zhang SX. Activation of endoplasmic reticulum stress by hyperglycemia is essential for Muller cell-derived inflammatory cytokine production in diabetes. Diabetes. 2012;61(2):492–504.View ArticlePubMed CentralPubMedGoogle Scholar
- Gordon S. Pattern recognition receptors: doubling up for the innate immune response. Cell. 2002;111(7):927–30.View ArticlePubMedGoogle Scholar
- Ohnishi H, Tochio H, Kato Z, Orii KE, Li A, Kimura T, et al. Structural basis for the multiple interactions of the MyD88 TIR domain in TLR4 signaling. Proc Natl Acad Sci U S A. 2009;106(25):10260–5.View ArticlePubMed CentralPubMedGoogle Scholar
- Komura T, Sakai Y, Honda M, Takamura T, Wada T, Kaneko S. ER stress induced impaired TLR signaling and macrophage differentiation of human monocytes. Cell Immunol. 2013;282(1):44–52.View ArticlePubMedGoogle Scholar
- Rao J, Yue S, Fu Y, Zhu J, Wang X, Busuttil RW, et al. ATF6 mediates a pro-inflammatory synergy between ER stress and TLR activation in the pathogenesis of liver ischemia-reperfusion injury. Am J Transplant. 2014;14(7):1552–61.View ArticlePubMedGoogle Scholar
- DeLay ML, Turner MJ, Klenk EI, Smith JA, Sowders DP, Colbert RA. HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats. Arthritis Rheum. 2009;60(9):2633–43.View ArticlePubMed CentralPubMedGoogle Scholar
- Martinon F, Chen X, Lee AH, Glimcher LH. TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages. Nat Immunol. 2010;11(5):411–8.View ArticlePubMed CentralPubMedGoogle Scholar
- Woo CW, Cui D, Arellano J, Dorweiler B, Harding H, Fitzgerald KA, et al. Adaptive suppression of the ATF4-CHOP branch of the unfolded protein response by toll-like receptor signalling. Nat Cell Biol. 2009;11(12):1473–80.View ArticlePubMed CentralPubMedGoogle Scholar
- Su X, Sorenson CM, Sheibani N. Isolation and characterization of murine retinal endothelial cells. Mol Vis. 2003;9:171–8.PubMedGoogle Scholar
- Zhang H, He Y, Dai S, Xu Z, Luo Y, Wan T, et al. AIP1 functions as an endogenous inhibitor of VEGFR2-mediated signaling and inflammatory angiogenesis in mice. J Clin Invest. 2008;118(12):3904–16.View ArticlePubMed CentralPubMedGoogle Scholar
- Gargalovic PS, Gharavi NM, Clark MJ, Pagnon J, Yang WP, He A, et al. The unfolded protein response is an important regulator of inflammatory genes in endothelial cells. Arterioscler Thromb Vasc Biol. 2006;26(11):2490–6.View ArticlePubMedGoogle Scholar
- Muller WA. Mechanisms of transendothelial migration of leukocytes. Circ Res. 2009;105(3):223–30.View ArticlePubMed CentralPubMedGoogle Scholar
- Suragani RN, Zachariah RS, Velazquez JG, Liu S, Sun CW, Townes TM, et al. Heme-regulated eIF2alpha kinase activated Atf4 signaling pathway in oxidative stress and erythropoiesis. Blood. 2012;119(22):5276–84.View ArticlePubMed CentralPubMedGoogle Scholar
- Lange PS, Chavez JC, Pinto JT, Coppola G, Sun CW, Townes TM, et al. ATF4 is an oxidative stress-inducible, prodeath transcription factor in neurons in vitro and in vivo. J Exp Med. 2008;205(5):1227–42.View ArticlePubMed CentralPubMedGoogle Scholar
- Bouman L, Schlierf A, Lutz AK, Shan J, Deinlein A, Kast J, et al. Parkin is transcriptionally regulated by ATF4: evidence for an interconnection between mitochondrial stress and ER stress. Cell Death Differ. 2011;18(5):769–82.View ArticlePubMed CentralPubMedGoogle Scholar
- Jiang HY, Jiang L, Wek RC. The eukaryotic initiation factor-2 kinase pathway facilitates differential GADD45a expression in response to environmental stress. J Biol Chem. 2007;282(6):3755–65.View ArticlePubMedGoogle Scholar
- Lenna S, Chrobak I, Farina GA, Rodriguez-Pascual F, Lamas S, Lafyatis R, et al. HLA-B35 and dsRNA induce endothelin-1 via activation of ATF4 in human microvascular endothelial cells. PLoS One. 2013;8(2), e56123.View ArticlePubMed CentralPubMedGoogle Scholar
- Bandow K, Maeda A, Kakimoto K, Kusuyama J, Shamoto M, Ohnishi T, et al. Molecular mechanisms of the inhibitory effect of lipopolysaccharide (LPS) on osteoblast differentiation. Biochem Biophys Res Commun. 2010;402(4):755–61.View ArticlePubMedGoogle Scholar
- Shimasaki S, Koga T, Shuto T, Suico MA, Sato T, Watanabe K, et al. Endoplasmic reticulum stress increases the expression and function of toll-like receptor-2 in epithelial cells. Biochem Biophys Res Commun. 2010;402(2):235–40.View ArticlePubMedGoogle Scholar
- He B. Viruses, endoplasmic reticulum stress, and interferon responses. Cell Death Differ. 2006;13(3):393–403.View ArticlePubMedGoogle Scholar
- Ambrose RL, Mackenzie JM. West Nile virus differentially modulates the unfolded protein response to facilitate replication and immune evasion. J Virol. 2011;85(6):2723–32.View ArticlePubMed CentralPubMedGoogle Scholar
- Qian Z, Xuan B, Chapa TJ, Gualberto N, Yu D. Murine cytomegalovirus targets transcription factor ATF4 to exploit the unfolded-protein response. J Virol. 2012;86(12):6712–23.View ArticlePubMed CentralPubMedGoogle Scholar
- Xuan B, Qian Z, Torigoi E, Yu D. Human cytomegalovirus protein pUL38 induces ATF4 expression, inhibits persistent JNK phosphorylation, and suppresses endoplasmic reticulum stress-induced cell death. J Virol. 2009;83(8):3463–74.View ArticlePubMed CentralPubMedGoogle Scholar
- Caselli E, Benedetti S, Grigolato J, Caruso A, Di Luca D. Activating transcription factor 4 (ATF4) is upregulated by human herpesvirus 8 infection, increases virus replication and promotes proangiogenic properties. Arch Virol. 2012;157(1):63–74.View ArticlePubMedGoogle Scholar
- Cho HK, Cheong KJ, Kim HY, Cheong J. Endoplasmic reticulum stress induced by hepatitis B virus X protein enhances cyclo-oxygenase 2 expression via activating transcription factor 4. Biochem J. 2011;435(2):431–9.View ArticlePubMedGoogle Scholar
- Zhang C, Bai N, Chang A, Zhang Z, Yin J, Shen W, et al. ATF4 is directly recruited by TLR4 signaling and positively regulates TLR4-trigged cytokine production in human monocytes. Cell Mol Immunol. 2013;10(1):84–94.View ArticlePubMed CentralPubMedGoogle Scholar
- Hodge DL, Reynolds D, Cerban FM, Correa SG, Baez NS, Young HA, et al. MCP-1/CCR2 interactions direct migration of peripheral B and T lymphocytes to the thymus during acute infectious/inflammatory processes. Eur J Immunol. 2012;42(10):2644–54.View ArticlePubMed CentralPubMedGoogle Scholar
- Schuette-Nuetgen K, Strecker JK, Minnerup J, Ringelstein EB, Schilling M. MCP-1/CCR-2-double-deficiency severely impairs the migration of hematogenous inflammatory cells following transient cerebral ischemia in mice. Exp Neurol. 2012;233(2):849–58.View ArticlePubMedGoogle Scholar
- Gerszten RE, Garcia-Zepeda EA, Lim YC, Yoshida M, Ding HA, Gimbrone Jr MA, et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature. 1999;398(6729):718–23.View ArticlePubMedGoogle Scholar
- Maus U, Henning S, Wenschuh H, Mayer K, Seeger W, Lohmeyer J. Role of endothelial MCP-1 in monocyte adhesion to inflamed human endothelium under physiological flow. Am J Physiol Heart Circ Physiol. 2002;283(6):H2584–2591.View ArticlePubMedGoogle Scholar
- Hirano H, Yoshioka T, Yunoue S, Fujio S, Yonezawa H, Niiro T, et al. TLR4, IL-6, IL-18, MyD88 and HMGB1 are highly expressed in intracranial inflammatory lesions and the IgG4/IgG ratio correlates with TLR4 and IL-6. Neuropathology. 2012;32(6):628–37.View ArticlePubMedGoogle Scholar
- Mitchell D, Yong M, Schroder W, Black M, Tirrell M, Olive C. Dual stimulation of MyD88-dependent Toll-like receptors induces synergistically enhanced production of inflammatory cytokines in murine bone marrow-derived dendritic cells. J Infect Dis. 2010;202(2):318–29.View ArticlePubMedGoogle Scholar
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.